BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30287053)

  • 1. Celastrol Reverses Palmitic Acid-Induced Insulin Resistance in HepG2 Cells via Restoring the miR-223 and GLUT4 Pathway.
    Zhang X; Xue XC; Wang Y; Cao FF; You J; Uzan G; Peng B; Zhang DH
    Can J Diabetes; 2019 Apr; 43(3):165-172. PubMed ID: 30287053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celastrol reverses palmitic acid (PA)-caused TLR4-MD2 activation-dependent insulin resistance via disrupting MD2-related cellular binding to PA.
    Zhang X; Wang Y; Ge HY; Gu YJ; Cao FF; Yang CX; Uzan G; Peng B; Zhang DH
    J Cell Physiol; 2018 Oct; 233(10):6814-6824. PubMed ID: 29667734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitic Acid Induces MicroRNA-221 Expression to Decrease Glucose Uptake in HepG2 Cells via the PI3K/AKT/GLUT4 Pathway.
    Huang F; Chen J; Wang J; Zhu P; Lin W
    Biomed Res Int; 2019; 2019():8171989. PubMed ID: 31828133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis inhibitors reduce celastrol toxicity and preserve its insulin sensitizing effects in insulin resistant HepG2 cells.
    Liu JJ; Zhang X; Cai BL; Qi MM; Chi YB; Peng B; Zhang DH
    J Integr Med; 2024 May; 22(3):286-294. PubMed ID: 38565435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF-α and regulating the expression of insulin signal transduction proteins.
    Gao F; Jian L; Zafar MI; Du W; Cai Q; Shafqat RA; Lu F
    Mol Med Rep; 2015 Nov; 12(5):6555-60. PubMed ID: 26352439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-191 blocking the translocation of GLUT4 is involved in arsenite-induced hepatic insulin resistance through inhibiting the IRS1/AKT pathway.
    Li W; Wu L; Sun Q; Yang Q; Xue J; Shi M; Tang H; Zhang J; Liu Q
    Ecotoxicol Environ Saf; 2021 Jun; 215():112130. PubMed ID: 33743404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Insulin Resistance by Multiple MiRNAs via Targeting the GLUT4 Signalling Pathway.
    Zhou T; Meng X; Che H; Shen N; Xiao D; Song X; Liang M; Fu X; Ju J; Li Y; Xu C; Zhang Y; Wang L
    Cell Physiol Biochem; 2016; 38(5):2063-78. PubMed ID: 27165190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance.
    Chen YH; Heneidi S; Lee JM; Layman LC; Stepp DW; Gamboa GM; Chen BS; Chazenbalk G; Azziz R
    Diabetes; 2013 Jul; 62(7):2278-86. PubMed ID: 23493574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleic Acid and Eicosapentaenoic Acid Reverse Palmitic Acid-induced Insulin Resistance in Human HepG2 Cells via the Reactive Oxygen Species/JUN Pathway.
    Sun Y; Wang J; Guo X; Zhu N; Niu L; Ding X; Xie Z; Chen X; Yang F
    Genomics Proteomics Bioinformatics; 2021 Oct; 19(5):754-771. PubMed ID: 33631425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue.
    Ling HY; Hu B; Hu XB; Zhong J; Feng SD; Qin L; Liu G; Wen GB; Liao DF
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):553-9. PubMed ID: 22956257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-17 impairs glucose metabolism in insulin-resistant skeletal muscle via repressing glucose transporter 4 expression.
    Xiao D; Zhou T; Fu Y; Wang R; Zhang H; Li M; Lin Y; Li Z; Xu C; Yang B; Zhang Y; Zhang Y
    Eur J Pharmacol; 2018 Nov; 838():170-176. PubMed ID: 30170066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geniposide promotes autophagy to inhibit insulin resistance in HepG2 cells via P62/NF‑κB/GLUT‑4.
    Jiang H; Ma Y; Yan J; Liu J; Li L
    Mol Med Rep; 2017 Nov; 16(5):7237-7244. PubMed ID: 28944847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-3138 deteriorates the insulin resistance of HUVECs via KSR2/AMPK/GLUT4 signaling pathway.
    Chen Y; Lin D; Shi C; Guo L; Liu L; Chen L; Li T; Liu Y; Zheng C; Chi X; Meng C; Xue Y
    Cell Cycle; 2021 Feb; 20(4):353-368. PubMed ID: 33509040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells.
    Abu Bakar MH; Cheng KK; Sarmidi MR; Yaakob H; Huri HZ
    Molecules; 2015 May; 20(5):8242-69. PubMed ID: 25961164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mangiferin Improved Palmitate-Induced-Insulin Resistance by Promoting Free Fatty Acid Metabolism in HepG2 and C2C12 Cells via PPAR
    Zhang Q; Kong X; Yuan H; Guan H; Li Y; Niu Y
    J Diabetes Res; 2019; 2019():2052675. PubMed ID: 30809553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Insulin Resistance by Myo-Inositol Is Associated with Suppressed Interleukin 6/Phospho-STAT3 Signaling in a Rat Polycystic Ovary Syndrome Model.
    Zhang Y; Li C; Zhang W; Zheng X; Chen X
    J Med Food; 2020 Apr; 23(4):375-387. PubMed ID: 32045334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hesperidin ameliorates insulin resistance by regulating the IRS1-GLUT2 pathway via TLR4 in HepG2 cells.
    Xuguang H; Aofei T; Tao L; Longyan Z; Weijian B; Jiao G
    Phytother Res; 2019 Jun; 33(6):1697-1705. PubMed ID: 31074547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-138-5p affects insulin resistance to regulate type 2 diabetes progression through inducing autophagy in HepG2 cells by regulating SIRT1.
    Luan B; Sun C
    Nutr Res; 2018 Nov; 59():90-98. PubMed ID: 30442237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells.
    Dong L; Hou X; Liu F; Tao H; Zhang Y; Zhao H; Song G
    Cell Biol Int; 2019 May; 43(5):553-564. PubMed ID: 30958584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic acid ameliorates oxidative stress and insulin resistance in high glucose-treated HepG2 cells via miR-223/keap1-Nrf2 pathway.
    Ding X; Jian T; Wu Y; Zuo Y; Li J; Lv H; Ma L; Ren B; Zhao L; Li W; Chen J
    Biomed Pharmacother; 2019 Feb; 110():85-94. PubMed ID: 30466006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.